What Changed at GeneDx

GeneDx introduced Easy Order at the 2026 American Academy of Pediatrics meeting. It is built for general pediatricians rather than genetics specialists and covers exome and genome testing from ordering through results, including how results are shared with families.

Our read

Genomic testing in children is often held up by referral queues for genetics clinics. A workflow built for general pediatricians is GeneDx's bid to move first line testing into routine care.

GeneDx published results from a study at Seattle Children's supporting hospital wide adoption of rapid genomic sequencing rather than the usual narrow deployment in the NICU or a single specialty service. The study evaluates both clinical and operational impact of running rapid sequencing across a whole pediatric institution, which is the question health systems actually face when deciding how far to extend a genomics program.

Our read

Evidence generated at a named academic pediatric center is a stronger basis for a capital decision than vendor authored case studies, and hospital wide is a meaningfully harder claim than a single unit pilot. Buyers evaluating a genomics program should read the operational half closely, since diagnostic yield is usually the easy part and turnaround time, ordering workflow and counseling capacity are what determine whether the program survives contact with a general ward.

GeneDx introduced Exome-to-Genome Reflex ordering within Epic Aura and other supported point-to-point EHR integrations. This capability allows providers to automatically trigger a genome test if the initial exome test results are negative or inconclusive.

Our read

This integration streamlines the diagnostic workflow for clinicians using Epic by eliminating the need to manually place secondary orders. It reduces administrative friction and can accelerate the time to a definitive genetic diagnosis for patients.

GeneDx launched a new digital offering that enables families of children with global developmental delay, intellectual disability, or epilepsy to initiate exome testing directly from its website. The service connects families with licensed virtual clinicians who review medical histories, order genetic testing, and deliver results without requiring an in-person visit.

Our read

This provides a direct-to-family acquisition channel that circumvents specialty care wait times, which can exceed a year for genetics appointments. Health systems and providers can leverage this virtual-first pathway to complement traditional care and accelerate time-to-diagnosis for pediatric patients.